SYROS PHARMACEUTICALS, INC. Operating Income
SYROS PHARMACEUTICALS, INC. reported Operating Income of -$26.18 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-09-30 was -$26.18M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-06-30 was -$27.42M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2024-03-31 was -$30.92M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2023-12-31 was -$27.14M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$128.99M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$135.87M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for fiscal 2021 was -$99.42M.
- SYROS PHARMACEUTICALS, INC. operating income (loss) for fiscal 2020 was -$82.30M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$26.18M 10-Q · filed 2024-10-31 | -$53.60M derived: sum of 2 quarters · filed 2024-10-31 | -$84.52M 10-Q · filed 2024-10-31 | -$111.66M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | -$27.42M 10-Q · filed 2024-07-31 | -$58.34M 10-Q · filed 2024-07-31 | -$85.48M derived: sum of 3 quarters · filed 2024-07-31 | -$120.11M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-03-31 | -$30.92M 10-Q · filed 2024-05-14 | -$58.06M derived: sum of 2 quarters · filed 2024-05-14 | -$92.70M derived: sum of 3 quarters · filed 2024-10-31 | -$126.70M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-12-31 | -$27.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$61.78M derived: sum of 2 quarters · filed 2024-10-31 | -$95.78M derived: sum of 3 quarters · filed 2024-10-31 | -$128.99M 10-K · filed 2024-03-27 |
| 2023-09-30 | -$34.64M 10-Q · filed 2024-10-31 | -$68.64M derived: sum of 2 quarters · filed 2024-10-31 | -$101.85M 10-Q · filed 2024-10-31 | -$137.84M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$34.00M 10-Q · filed 2024-07-31 | -$67.21M 10-Q · filed 2024-07-31 | -$103.21M derived: sum of 3 quarters · filed 2024-07-31 | -$142.66M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | -$33.21M 10-Q · filed 2024-05-14 | -$69.21M derived: sum of 2 quarters · filed 2024-05-14 | -$108.66M derived: sum of 3 quarters · filed 2024-05-14 | -$142.43M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$75.45M derived: sum of 2 quarters · filed 2024-03-27 | -$109.22M derived: sum of 3 quarters · filed 2024-03-27 | -$135.87M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$39.45M 10-Q · filed 2023-11-14 | -$73.22M derived: sum of 2 quarters · filed 2023-11-14 | -$99.88M 10-Q · filed 2023-11-14 | -$125.30M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$33.77M 10-Q · filed 2023-08-08 | -$60.42M 10-Q · filed 2023-08-08 | -$85.84M derived: sum of 3 quarters · filed 2023-08-08 | -$112.76M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$26.65M 10-Q · filed 2023-05-10 | -$52.08M derived: sum of 2 quarters · filed 2023-05-10 | -$78.99M derived: sum of 3 quarters · filed 2023-05-10 | -$105.13M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$25.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$52.33M derived: sum of 2 quarters · filed 2023-03-02 | -$78.48M derived: sum of 3 quarters · filed 2023-03-02 | -$99.42M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$26.91M 10-Q · filed 2022-11-14 | -$53.05M derived: sum of 2 quarters · filed 2022-11-14 | -$74.00M 10-Q · filed 2022-11-14 | -$103.22M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$26.14M 10-Q · filed 2022-08-09 | -$47.09M 10-Q · filed 2022-08-09 | -$76.31M derived: sum of 3 quarters · filed 2022-08-09 | -$95.30M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$20.94M 10-Q · filed 2022-05-16 | -$50.16M derived: sum of 2 quarters · filed 2022-05-16 | -$69.16M derived: sum of 3 quarters · filed 2022-05-16 | -$85.90M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$29.22M 10-K · filed 2021-03-04 | -$48.22M derived: sum of 2 quarters · filed 2021-11-05 | -$64.96M derived: sum of 3 quarters · filed 2021-11-05 | -$82.30M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$19.00M 10-Q · filed 2021-11-05 | -$35.74M derived: sum of 2 quarters · filed 2021-11-05 | -$53.08M 10-Q · filed 2021-11-05 | -$73.25M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | -$16.74M 10-Q · filed 2021-08-05 | -$34.08M 10-Q · filed 2021-08-05 | -$54.25M derived: sum of 3 quarters · filed 2021-08-05 | -$74.64M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$17.34M 10-Q · filed 2021-05-06 | -$37.51M derived: sum of 2 quarters · filed 2021-05-06 | -$57.90M derived: sum of 3 quarters · filed 2021-05-06 | -$78.11M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$20.17M 10-K · filed 2021-03-04 | -$40.56M derived: sum of 2 quarters · filed 2021-03-04 | -$60.77M derived: sum of 3 quarters · filed 2021-03-04 | -$77.74M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$20.39M 10-K · filed 2021-03-04 | -$40.60M derived: sum of 2 quarters · filed 2021-03-04 | -$57.57M 10-Q · filed 2020-11-05 | -$76.18M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$20.21M 10-K · filed 2021-03-04 | -$37.18M 10-Q · filed 2020-08-06 | -$55.79M derived: sum of 3 quarters · filed 2021-03-04 | -$72.11M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$16.97M 10-K · filed 2021-03-04 | -$35.58M derived: sum of 2 quarters · filed 2021-03-04 | -$51.90M derived: sum of 3 quarters · filed 2021-03-04 | -$66.45M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$18.61M 10-K · filed 2020-03-05 | -$34.93M derived: sum of 2 quarters · filed 2020-03-05 | -$49.48M derived: sum of 3 quarters · filed 2020-03-05 | -$64.30M 10-K · filed 2021-03-04 |
| 2018-09-30 | -$16.32M 10-K · filed 2020-03-05 | -$30.87M derived: sum of 2 quarters · filed 2020-03-05 | -$45.69M 10-Q · filed 2019-11-12 | -$61.21M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | -$14.55M 10-K · filed 2020-03-05 | -$29.37M 10-Q · filed 2019-08-01 | -$44.89M derived: sum of 3 quarters · filed 2020-03-05 | -$58.93M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | -$14.82M 10-K · filed 2020-03-05 | -$30.34M derived: sum of 2 quarters · filed 2020-03-05 | -$44.38M derived: sum of 3 quarters · filed 2020-03-05 | -$57.89M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | -$15.52M 10-K · filed 2019-03-07 | -$29.56M derived: sum of 2 quarters · filed 2019-03-07 | -$43.07M derived: sum of 3 quarters · filed 2019-03-07 | -$54.69M 10-K · filed 2020-03-05 |
| 2017-09-30 | -$14.04M 10-K · filed 2019-03-07 | -$27.55M derived: sum of 2 quarters · filed 2019-03-07 | -$39.17M 10-Q · filed 2018-11-01 | -$50.21M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$13.51M 10-K · filed 2019-03-07 | -$25.13M 10-Q · filed 2018-08-07 | -$36.17M derived: sum of 3 quarters · filed 2019-03-07 | -$50.39M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$11.61M 10-K · filed 2019-03-07 | -$22.66M derived: sum of 2 quarters · filed 2019-03-07 | -$36.88M derived: sum of 3 quarters · filed 2019-03-07 | -$48.94M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$11.04M 10-K · filed 2018-03-12 | -$25.26M derived: sum of 2 quarters · filed 2018-03-12 | -$37.33M derived: sum of 3 quarters · filed 2018-03-12 | -$47.96M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$14.22M 10-K · filed 2018-03-12 | -$26.28M derived: sum of 2 quarters · filed 2018-03-12 | -$36.92M 10-Q · filed 2017-11-08 | -$47.61M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$12.06M 10-K · filed 2018-03-12 | -$22.70M 10-Q · filed 2017-08-09 | -$33.39M derived: sum of 3 quarters · filed 2018-03-12 | -$41.85M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$10.64M 10-K · filed 2018-03-12 | -$21.32M derived: sum of 2 quarters · filed 2018-03-12 | -$29.79M derived: sum of 3 quarters · filed 2018-03-12 | -$35.88M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$10.69M 10-K · filed 2017-03-20 | -$19.15M derived: sum of 2 quarters · filed 2017-03-20 | -$25.25M derived: sum of 3 quarters · filed 2017-03-20 | -$29.82M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$8.46M 10-K · filed 2017-03-20 | -$14.56M derived: sum of 2 quarters · filed 2017-03-20 | -$19.13M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$6.09M 10-K · filed 2017-03-20 | -$10.67M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -$4.57M 10-K · filed 2017-03-20 | |||
| 2014-12-31 | -$13.44M 10-K · filed 2017-03-20 |